AdvaMed Asks For Changes In Guidance On PMA Pre-Approval Inspections
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is recommending that FDA be both more flexible and more specific in its policies on manufacturing inspections conducted as part of the premarket approval process